Biotech | July 26, 2023
TransCure bioServices partners with Preclina to expands reach into APAC
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
For the treatment of Superficial Femoral Artery
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Subscribe To Our Newsletter & Stay Updated
